Amneal Pharmaceuticals
S&P 600
$17.01
+0.83%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Return on equity is healthy at 218.2%.
- Return on capital employed is moderate at 13.6%.
- Current assets comfortably cover current liabilities (current ratio 2.17).
!Watch-points
- Higher leverage: debt-to-equity of 77.88 is above 1.
- Net profit margin is slim at 2.4%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Piotroski F-ScoreStrong
7 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$5.92B
Current Price$ 17.01
High / Low$ 19.26 / 9.49
Stock P/E35.4375
Book Value$ 0.10
Dividend Yield0%
ROCE13.61%
ROE218.20%
Debt to Equity77.88
Current Ratio2.17
P/B Ratio165.14563
EPS$ 0.22
Debt$2.57B
PAT Margin2.39%
Cash PAT$129.36M